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Table 1
Cells/mm3 All Patients TFM/Cy FluBu2/ATG CB P value
CD3- D30 284 376 277 16.5 <0.0001
D100 518 598.5 1159 125 <0.0001
1 year 669 744.5 690 244 0.13
CD4- D30 100 111 129.5 4 <0.0001
D100 175 189 276 53 <0.0001
1 year 251 293 269 141 0.08
CD19- D30 2 1 8 2 <0.0001
D100 41.5 24 73.5 273.5 0.03
1 year 184.5 204 96 925 0.01
T-reg D30 14 16 10.5 2 0.06
D100 18.5 20 29.1 5.5 0.13
1 year 22 21.5 38 12.5 0.14
NK-cells- D30 136 29 205 264 <0.0001
D100 150 110 201 269 0.001
1 year 143 132.5 148 166 0.53
IgA- D30 59 46 147 54 <0.0001
D100 60.5 26 131 33.5 <0.0001
1 year 58 51 45 77.5 0.13
IgG- D30 593 534 763 548 0.01
D100 612 494 656 592 0.45
1 year 760 784 742 878 0.46
IgM- D30 29 23.1 58.6 28.1 0.01
D100 30.2 17.0 80.2 58.9 <0.0001
1 year 52.2 42.2 53.8 81.1 0.25
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ATG conditioning was associated with faster recovery of NK-
cells and CD19 cell; however with delayed recovery of T-
lymphocyte subsets. Recovery of T-lymphocyte subsets was
almost comparable in both arms receiving allo-SCT with RIC
regimen regardless of the use of post-tx Cy vs ATG. FluBu2/
ATG regimen was associated with faster recovery of serum
Ig’s in the early post-transplant period.
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Umbilical cord blood transplantation (UCBT) is characterized
by delayed immune reconstitution even with the use of
double unit UCBT (dUCBT). Previously we reported that
reconstitution of thymopoiesis, as determined by assessment
of T-cell receptor excision circles (TRECs), plays a critical role
in the clearance of CMV viremia and is associated with
improved overall survival in dUCBT recipients. We also
determined that recovery of speciﬁc T-cell subsets after
dUCBTcorrelates with serum levels of Interleukin 7 (IL-7) and
Stem Cell Factor (SCF). Here we investigated whether thymic
reconstitution depends on IL-7 and SCF and examined the
prognostic role of TRECs, IL-7 and SCF levels in clinical out-
comes after dUCBT. Fifty-two patients with hematologic ma-
lignancies received dUCBT following either reduced-intensity
(ﬂudarabine, melphalan and antithymocyte globulin) or
myeloablative conditioning (ﬂudarabine, cyclophosphamide
and TBI). GvHD prophylaxis was tacrolimus in combination
with sirolimus ormycophenolatemofetil. The incidence rates
of grade II-IV acute GvHD and chronic GvHD were 15.4% and
29% respectively. The 5-year cumulative incidence of relapse,non-relapse mortality (NRM), progression-free survival (PFS)
and overall survival (OS) were 43%, 31%, 26%, and 41%
respectively. During the ﬁrst 3 months after dUCBT, TRECs
remained undetectable or extremely low but, at 6 months,
69.7% of patients had detectable levels. At one year, TRECs
were detectable in 86.6% of patients with a median value of
2404 copies/ug DNA. Serum levels of IL-7 increased 3-fold
from baseline by 1 month after dUCBT, remained elevated
through the ﬁrst 3 months, and gradually declined to pre-
transplant levels by1 year. SCF levels peakedat 2months after
dUCBT and gradually declined thereafter. We observed a sta-
tistically signiﬁcant inverse correlationbetweenTRECsand IL-
7 (p¼0.036) or SCF (p<0.02) serum levels at various time
points after dUCBT, suggesting that uptake of these two cy-
tokines by thymocytes may lead to their differentiation into
TREC-containing Recent Thymic Emigrants (RTE). In multi-
variable analysis, higherTREC levels independentlycorrelated
with improved OS (p¼0.02) and lower NRM (p¼0.008).
Conversely, higher levels of SCFand IL-7 correlatedwith lower
OS (p¼0.005andp<0.0001). Furthermore, SCF level predicted
NRM (p¼0.003), whereas serum IL-7 level independently
predicted cGvHD (p¼0.03). Taken together, our ﬁndings sug-
gest that high IL-7 and SCF serum levels are associated with
delayed thymic reconstitution and may predict adverse out-
comes after dUCBT, including cGvHD, NRM and OS.
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